![]() | This article contains content that is written like
an advertisement. (February 2020) |
![]() | |
Company type | Clinical trial platform |
---|---|
Industry | |
Headquarters | |
Key people | Chris Venezia |
Products | ProofPilot |
Website |
www |
ProofPilot is an American Internet company with offices in New York City. Its namesake product is a digital protocol automation platform that aims to eliminate guesswork and protocol deviations[ how?] in clinical settings. Chris Venezia joined as the Chief Executive Officer in 2022. [1]
ProofPilot grew out of the consulting firm Cyclogram in 2013. Matthew Amsden started Cyclogram in 2005. [2]
Early versions of the platform supported studies in the United States, Brazil and Peru. [1] ProofPilot participated in the BluePrint Health Incubator program in the winter of 2014. [3]
Amsden has talked about the challenges of creating a digital health startup and the cultural disconnect between buyers and venture-capital-backed startups. He says that adhering to the typical venture-backed startup "rulebook" almost killed ProofPilot. [4] The company relaunched the product in late 2017 after not taking on customers for over two years. [5]
The ProofPilot platform is split in three parts. The first allows users the ability to design research studies. The design process (and resulting participant experience) is based on a concept called micro-interactions. [6] Non-experienced study designers can use study templates and fill in the blanks to create a study. [7] The second is the participant experience. After study designers launch the study, it goes through an automatic external regulatory review by Veritas IRB in Montreal, Quebec, Canada. [8] Then, participants begin to engage in the study via mobile phones and desktop computers. ProofPilot has publicly stated it has deprioritized development of a native iOS and Android application because Progressive web apps provide a better user experience. [9] The system also provides reporting of findings.
In September 2016, ProofPilot formed a partnership with Veritas IRB in Montreal, Quebec, Canada. Given that many of its customers are not academic institutions and don't have an in-house review process, all studies launched on ProofPilot will be reviewed by Veritas before going live. [10]
![]() | This article contains content that is written like
an advertisement. (February 2020) |
![]() | |
Company type | Clinical trial platform |
---|---|
Industry | |
Headquarters | |
Key people | Chris Venezia |
Products | ProofPilot |
Website |
www |
ProofPilot is an American Internet company with offices in New York City. Its namesake product is a digital protocol automation platform that aims to eliminate guesswork and protocol deviations[ how?] in clinical settings. Chris Venezia joined as the Chief Executive Officer in 2022. [1]
ProofPilot grew out of the consulting firm Cyclogram in 2013. Matthew Amsden started Cyclogram in 2005. [2]
Early versions of the platform supported studies in the United States, Brazil and Peru. [1] ProofPilot participated in the BluePrint Health Incubator program in the winter of 2014. [3]
Amsden has talked about the challenges of creating a digital health startup and the cultural disconnect between buyers and venture-capital-backed startups. He says that adhering to the typical venture-backed startup "rulebook" almost killed ProofPilot. [4] The company relaunched the product in late 2017 after not taking on customers for over two years. [5]
The ProofPilot platform is split in three parts. The first allows users the ability to design research studies. The design process (and resulting participant experience) is based on a concept called micro-interactions. [6] Non-experienced study designers can use study templates and fill in the blanks to create a study. [7] The second is the participant experience. After study designers launch the study, it goes through an automatic external regulatory review by Veritas IRB in Montreal, Quebec, Canada. [8] Then, participants begin to engage in the study via mobile phones and desktop computers. ProofPilot has publicly stated it has deprioritized development of a native iOS and Android application because Progressive web apps provide a better user experience. [9] The system also provides reporting of findings.
In September 2016, ProofPilot formed a partnership with Veritas IRB in Montreal, Quebec, Canada. Given that many of its customers are not academic institutions and don't have an in-house review process, all studies launched on ProofPilot will be reviewed by Veritas before going live. [10]